• Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.

    PubMed 
    Article 

    Google Scholar
     

  • Waks AG, Winer EP. Breast cancer treatment: A review. JAMA. 2019;321(3):288–300.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Malone ER, Oliva M, Sabatini PJB, Stockley TL, Siu LL. Molecular profiling for precision cancer therapies. Genome Med. 2020;12(1):8.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Shi Q, Li Y, Li S, Jin L, Lai H, Wu Y, Cai Z, Zhu M, Li Q, Li Y, et al. LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer. Nat Commun. 2020;11(1):5513.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Li X, Jin F, Li Y. A novel autophagy-related lncRNA prognostic risk model for breast cancer. J Cell Mol Med. 2021;25(1):4–14.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Rosario SR, Long MD, Affronti HC, Rowsam AM, Eng KH, Smiraglia DJ. Pan-cancer analysis of transcriptional metabolic dysregulation using the cancer genome atlas. Nat Commun. 2018;9(1):5330.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Gandhi N, Das GM. Metabolic reprogramming in breast cancer and its therapeutic implications. Cells. 2019;8(2):89.

    CAS 
    PubMed Central 
    Article 

    Google Scholar
     

  • Dias AS, Almeida CR, Helguero LA, Duarte IF. Metabolic crosstalk in the breast cancer microenvironment. Eur J Cancer. 2019;121:154–71.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Masri S, Sassone-Corsi P. The emerging link between cancer, metabolism, and circadian rhythms. Nat Med. 2018;24(12):1795–803.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Park JH, Pyun WY, Park HW. Cancer metabolism: phenotype, signaling and therapeutic targets. Cells. 2020;9(10):2308.

    CAS 
    PubMed Central 
    Article 

    Google Scholar
     

  • Koundouros N, Poulogiannis G. Reprogramming of fatty acid metabolism in cancer. Br J Cancer. 2020;122(1):4–22.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Jiang M, Liu S, Lin J, Hao W, Wei B, Gao Y, Kong C, Yu M, Zhu Y. A pan-cancer analysis of molecular characteristics and oncogenic role of hexokinase family genes in human tumors. Life Sci. 2021;264: 118669.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Lau E. Non-coding RNA: Zooming in on lncRNA functions. Nat Rev Genet. 2014;15(9):574–5.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Bhan A, Soleimani M, Mandal SS. Long noncoding rna and cancer: a new paradigm. Cancer Res. 2017;77(15):3965–81.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Cedro-Tanda A, Ríos-Romero M, Romero-Córdoba S, Cisneros-Villanueva M, Rebollar-Vega RG, Alfaro-Ruiz LA, Jiménez-Morales S, Domínguez-Reyes C, Villegas-Carlos F, Tenorio-Torres A, et al. A lncRNA landscape in breast cancer reveals a potential role for AC009283.1 in proliferation and apoptosis in HER2-enriched subtype. Sci Rep. 2020;10(1):13146.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Liang Y, Song X, Li Y, Chen B, Zhao W, Wang L, Zhang H, Liu Y, Han D, Zhang N, et al. LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis. Mol Cancer. 2020;19(1):85.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Quan M, Chen J, Zhang D. Exploring the secrets of long noncoding RNAs. Int J Mol Sci. 2015;16(3):5467–96.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Yousefi H, Maheronnaghsh M, Molaei F, Mashouri L, Reza Aref A, Momeny M, Alahari SK. Long noncoding RNAs and exosomal lncRNAs: classification, and mechanisms in breast cancer metastasis and drug resistance. Oncogene. 2020;39(5):953–74.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Zappe K, Cichna-Markl M. Aberrant DNA methylation of ABC transporters in cancer. Cells. 2020;9(10):2281.

    CAS 
    PubMed Central 
    Article 

    Google Scholar
     

  • Lau CE, Robinson O. DNA methylation age as a biomarker for cancer. Int J Cancer. 2021;148(11):2652–63.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Zhu P, He F, Hou Y, Tu G, Li Q, Jin T, Zeng H, Qin Y, Wan X, Qiao Y, et al. A novel hypoxic long noncoding RNA KB-1980E63 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability. Oncogene. 2021;40(9):1609–27.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Zhao BS, Roundtree IA, He C. Post-transcriptional gene regulation by mRNA modifications. Nat Rev Mol Cell Biol. 2017;18(1):31–42.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Guo FX, Wu Q, Li P, Zheng L, Ye S, Dai XY, Kang CM, Lu JB, Xu BM, Xu YJ, et al. The role of the LncRNA-FA2H-2-MLKL pathway in atherosclerosis by regulation of autophagy flux and inflammation through mTOR-dependent signaling. Cell Death Differ. 2019;26(9):1670–87.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Wang JY, Yang Y, Ma Y, Wang F, Xue A, Zhu J, Yang H, Chen Q, Chen M, Ye L, et al. Potential regulatory role of lncRNA-miRNA-mRNA axis in osteosarcoma. Biomed Pharmacother. 2020;121: 109627.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Chu W, Zhang X, Qi L, Fu Y, Wang P, Zhao W, Du J, Zhang J, Zhan J, Wang Y, et al. The EZH2-PHACTR2-AS1-ribosome axis induces genomic instability and promotes growth and metastasis in breast cancer. Cancer Res. 2020;80(13):2737–50.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7): e47.

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Scholar
     

  • Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27–30.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Tan YT, Lin JF, Li T, Li JJ, Xu RH, Ju HQ. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun (Lond). 2021;41(2):109–20.

    Article 

    Google Scholar
     

  • Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96–118.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Liu B, Sun L, Liu Q, Gong C, Yao Y, Lv X, Lin L, Yao H, Su F, Li D, et al. A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasis. Cancer Cell. 2015;27(3):370–81.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Dong H, Hu J, Zou K, Ye M, Chen Y, Wu C, Chen X, Han M. Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer. Mol Cancer. 2019;18(1):3.

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Scholar
     

  • Lin X, Dinglin X, Cao S, Zheng S, Wu C, Chen W, Li Q, Hu Q, Zheng F, Wu Z, et al. Enhancer-driven lncRNA BDNF-AS induces endocrine resistance and malignant progression of breast cancer through the RNH1/TRIM21/mTOR Cascade. Cell Rep. 2020;31(10): 107753.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Jin X, Ge LP, Li DQ, Shao ZM, Di GH, Xu XE, Jiang YZ. LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer. Mol Cancer. 2020;19(1):87.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Sang L, Ju HQ, Yang Z, Ge Q, Zhang Z, Liu F, Yang L, Gong H, Shi C, Qu L, et al. Mitochondrial long non-coding RNA GAS5 tunes TCA metabolism in response to nutrient stress. Nat Metab. 2021;3(1):90–106.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Morotti M, Zois CE, El-Ansari R, Craze ML, Rakha EA, Fan SJ, Valli A, Haider S, Goberdhan DCI, Green AR, et al. Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer. Br J Cancer. 2021;124(2):494–505.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Thomas M, Davis T, Nell T, Sishi B, Engelbrecht AM. Amino Acid starvation sensitizes resistant breast cancer to doxorubicin-induced cell death. Front Cell Dev Biol. 2020;8: 565915.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Wang Y, Chen J, Chen W, Liu L, Dong M, Ji J, Hu D, Zhang N. LINC00987 Ameliorates COPD by regulating LPS-induced cell apoptosis, oxidative stress, inflammation and autophagy through Let-7b-5p/SIRT1 Axis. Int J Chron Obstruct Pulmon Dis. 2020;15:3213–25.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Zhang F, Zeng L, Cai Q, Xu Z, Liu R, Zhong H, Mukiibi R, Deng L, Tang X, Xin H. Comprehensive analysis of a long noncoding RNA-associated competing endogenous RNA network in wilms tumor. Cancer Control. 2020;27(2):1073274820936991.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chen YT, Xiang D, Zhao XY, Chu XY. Upregulation of lncRNA NIFK-AS1 in hepatocellular carcinoma by m(6)A methylation promotes disease progression and sorafenib resistance. Hum Cell. 2021;34(6):1800–11.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Zhou YX, Zhao W, Mao LW, Wang YL, Xia LQ, Cao M, Shen J, Chen J. Long non-coding RNA NIFK-AS1 inhibits M2 polarization of macrophages in endometrial cancer through targeting miR-146a. Int J Biochem Cell Biol. 2018;104:25–33.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Wang D, Li J, Cai F, Xu Z, Li L, Zhu H, Liu W, Xu Q, Cao J, Sun J, et al. Overexpression of MAPT-AS1 is associated with better patient survival in breast cancer. Biochem Cell Biol. 2019;97(2):158–64.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Rights and permissions

    Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

    Disclaimer:

    This article is autogenerated using RSS feeds and has not been created or edited by OA JF.

    Click here for Source link (https://www.biomedcentral.com/)